Fora Capital, LLC Gilead Sciences, Inc. Transaction History

Fora Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$71.58 - $87.29 $1.53 Million - $1.86 Million	21,315 New	21,315 $1.56 Million
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $3.55 Million - $4.05 Million	46,706 New	46,706 $3.6 Million
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $215,925 - $270,578	-3,728 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $241,872 - $274,529	3,728 New	3,728 $271,000
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.18 Million - $1.34 Million	-19,645 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.11 Million - $1.27 Million	19,645 New	19,645 $1.14 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1.29 Million - $1.49 Million	-17,777 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $1.39 Million - $1.78 Million	-22,160 Reduced 55.49%	17,777 $1.33 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $2.46 Million - $2.71 Million	39,937 New	39,937 $2.6 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.